Profluent

Executive Director / Vice President, Biology & Translational Pharmacology

Profluent · Emeryville, California, United States; On-site

Posted about 2 months ago

or apply directly on Profluent's site. We never take the application ourselves.

Is this posting real?

This role has been open
63 days
Profluent's roles stay open a median of 63 days
Reposted
No
Salary listed
No
0% of Profluent's roles list one
Ghost-job risk at Profluent
high
12 stale, 0 reposted of 12 open
Hiring momentum
17 roles opened in the last 90 days
↑ up vs. the prior 90 days
Last confirmed on the employer's board
2026-10-05

Measured from postings appearing on and disappearing from Profluent's own greenhouse board since 2026-08-03. Full hiring picture for Profluent.

About this role

Profluent is looking for an Executive Director / Vice President to lead the scientific strategy for their gene editing therapeutic portfolio, focusing on liver-directed customized base editing for severe inborn metabolic diseases. The role involves overseeing translational biology and in vivo pharmacology, managing cross-functional therapeutic programs, and collaborating with various teams to generate data packages for development candidates. The ideal candidate will have extensive experience in genetic medicines and a strong understanding of liver biology and metabolic diseases.

Our read on this posting2.8out of 5
benefits
3/5
freshness
1/5
career value
5/5
role clarity
5/5
pay transparency
0/5

Scored from the posting itself — how clearly the role is described, how much it says about pay and benefits, and how recently it was listed. Not a judgement of Profluent as an employer.

What you need

  • PhD, MD, DVM, PharmD, or equivalent advanced degree in pharmacology, molecular biology, genetics, physiology, hepatology, bioengineering, medicine, or a related discipline
  • 12+ years of biopharma R&D experience with a strong track record in genetic medicines, liver biology, translational pharmacology, and preclinical development
  • Demonstrated track record advancing multiple therapeutic programs from concept through development candidate nomination
  • Deep understanding of liver biology and metabolic disease
  • Experience designing and interpreting in vivo pharmacology studies
  • Demonstrated ability to lead multidisciplinary scientific teams

Nice to have

  • Direct experience with genome editing is valuable but not required
  • Experience advancing at least one program into IND-enabling studies or clinical development is strongly preferred
  • Extensive experience with rare liver diseases, lipid biology, hepatology, fibrosis biology, and/or metabolic liver disease
  • Working knowledge of IND-enabling requirements, toxicology interfaces, CMC considerations, bioanalytical assay needs, and regulatory expectations
  • Direct experience or at least high-level familiarity with gene editing proteins such as nucleases, base editors, prime editors, recombinases

What you get

  • High-growth opportunity with meaningful impact on the future of protein design
  • Competitive compensation package with equity participation
  • 401(k) with a strong employer match
  • Comprehensive benefits including health/dental/vision insurance
  • Generous PTO policy and commitment to work-life balance
  • Professional development opportunities in a cutting-edge field at the intersection of AI and biology

Worth weighing

  • No remote work options mentioned, position is on-site
  • High level of responsibility and leadership required
  • Candidates must have ongoing work authorization in the United States that does not require employer sponsorship

Summarised from Profluent's posting. Read the full original.

Listed by Profluent on their greenhouse job board, last confirmed open on 2026-10-05. PitchMeAI is not the employer.

More roles at Profluent

All 12 open roles at Profluent →